Literature DB >> 15474455

E2F6: a member of the E2F family that does not modulate squamous differentiation.

Chung Fai Wong1, Liam M Barnes, Louise Smith, Claudia Popa, Magdalena M Serewko-Auret, Nicholas A Saunders.   

Abstract

The inhibition of E2F has been demonstrated to be important in the initiation of squamous differentiation by two independent manners: promotion of growth arrest and the relief of the differentiation-suppressive properties of E2Fs. E2F6 is reported to behave as a transcriptional repressor of the E2F family. In this study, we examined the ability of E2F6 to act as the molecular switch required for E2F inhibition in order for keratinocytes to enter a terminal differentiation programme. Results demonstrated that whilst E2F6 was able to suppress E2F activity in proliferating keratinocytes, it did not modulate squamous differentiation in a differentiated keratinocyte. Furthermore, inhibition of E2F, by overexpressing E2F6, was not sufficient to sensitise either proliferating keratinocytes or the squamous cell carcinoma cell line, KJD-1/SV40, to differentiation-inducing agents. Significantly, although E2F6 could suppress E2F activity in proliferating cells, it could not inhibit proliferation of KJD-1/SV40 cells. These results demonstrate that E2F6 does not contain the domains required for modulation of squamous differentiation and imply isoform-specific functions for individual E2F family members.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474455     DOI: 10.1016/j.bbrc.2004.09.084

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes.

Authors:  G J Ortiz; Y Li; S M Post; V Pant; S Xiong; C A Larsson; A K El-Naggar; D G Johnson; G Lozano
Journal:  Oncogene       Date:  2017-09-18       Impact factor: 9.867

Review 2.  The role of the E2F transcription factor family in UV-induced apoptosis.

Authors:  Mehlika Hazar-Rethinam; Liliana Endo-Munoz; Orla Gannon; Nicholas Saunders
Journal:  Int J Mol Sci       Date:  2011-12-06       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.